You have 8 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

B-lymphoid

Showing 26 - 50 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Acute Lymphoid Leukemia, Acute Lymphoblastic Leukemia Trial in Aurora (CD19 Directed CAR T Cell)

Not yet recruiting
  • Acute Lymphoid Leukemia
  • Acute Lymphoblastic Leukemia
  • CD19 Directed CAR T Cell
  • Aurora, Colorado
    University of Colorado Hospital
Sep 12, 2022

Relapsed Non-Hodgkin Lymphoma, Refractory Non-Hodgkin Lymphoma, Chronic Lymphocytic Leukemia Trial (BGB-21447)

Not yet recruiting
  • Relapsed Non-Hodgkin Lymphoma
  • +6 more
  • (no location specified)
Apr 12, 2023

Leukemia, Acute Lymphoblastic Leukemia Trial in New York (gene-modified T cells targeted)

Active, not recruiting
  • Leukemia
  • Acute Lymphoblastic Leukemia
  • gene-modified T cells targeted
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Feb 1, 2023

Acute Lymphoblastic Leukemia, Acute Lymphoblastic Leukemia, in Relapse, Refractory Acute Lymphoid Leukemia Trial in Beijing

Recruiting
  • Acute Lymphoblastic Leukemia
  • +2 more
  • chimeric antigen receptor T cell
  • Beijing, Beijing, China
    Beijing Boren Hospital
Aug 12, 2022

Lymphoblastic Leukemia Trial in Palo Alto (Dasatinib)

Not yet recruiting
  • Lymphoblastic Leukemia
  • Palo Alto, California
    Stanford University
Aug 14, 2023

Non Hodgkin Lymphoma, Acute Lymphoblastic Leukemia, Chronic Lymphocytic Leukemia Trial in Cleveland (Fully human anti CD19 CAR-T

Recruiting
  • Non Hodgkin Lymphoma
  • +2 more
  • Fully human anti CD19 CAR-T Cell Dose
  • +2 more
  • Cleveland, Ohio
    University Hospitals Cleveland Medical Center, Case Comprehensiv
Oct 4, 2022

Relapsed or Refractory CD19+ B-cell Lymphoma, Relapsed or Refractory Chronic Lymphocytic Leukemia, Relapsed or Refractory Small

Recruiting
  • Relapsed or Refractory CD19+ B-cell Lymphoma
  • +2 more
  • TBI-2001
  • +2 more
  • Toronto, Ontario, Canada
    Princess Margaret Cancer Centre
Jul 26, 2023

B-cell Acute Lymphoblastic Leukemia Trial (single dose of CNCT19)

Not yet recruiting
  • B-cell Acute Lymphoblastic Leukemia
  • single dose of CNCT19
  • (no location specified)
Dec 19, 2022

Leukemia, Lymphocytic, Chronic, B-Cell, Small Lymphocytic Lymphoma Trial (Ibrutinib, Venetoclax)

Not yet recruiting
  • Leukemia, Lymphocytic, Chronic, B-Cell
  • Small Lymphocytic Lymphoma
  • (no location specified)
Jul 19, 2023

B-cell Acute Lymphoblastic Leukemia, B-ALL Trial in Kunming (U-CAR-T Cells (LstCAR019))

Withdrawn
  • B-cell Acute Lymphoblastic Leukemia
  • B-ALL
  • U-CAR-T Cells (LstCAR019)
  • Kunming, Yunnan, China
    Kunming Hope of Health Hospital
Nov 27, 2022

Non Hodgkin Lymphoma, Chronic Lymphocytic Leukemia Trial in Fairway, Houston (SC291)

Recruiting
  • Non Hodgkin Lymphoma
  • Chronic Lymphocytic Leukemia
  • Fairway, Kansas
  • +1 more
May 30, 2023

Follicular B-cell Non-Hodgkin's Lymphoma, Mantle Cell Lymphoma Recurrent, Mantle Cell Lymphoma Refractory Trial in Orange,

Recruiting
  • Follicular B-cell Non-Hodgkin's Lymphoma
  • +7 more
  • MB-106
  • Orange, California
  • +3 more
Nov 1, 2022

B-cell Acute Lymphoblastic Leukemia, B-ALL Trial in Kunming (UCAR-T Cells)

Recruiting
  • B-cell Acute Lymphoblastic Leukemia
  • B-ALL
  • UCAR-T Cells
  • Kunming, Yunnan, China
    920th Hospital of Joint Logistics Support Force of People's Libe
Dec 7, 2022

Determination of Blood Tumor Cells

Completed
  • Leukemia, Lymphocytic, Chronic, B-Cell
  • Abnormalities Cell Epithelial
    • Zurich, Switzerland
      University Hospital Zurich
    Jan 9, 2023

    B-type Chronic Lymphocytic Leukemia Subgroups: Maturation Stage

    Active, not recruiting
    • Chronic Lymphocytic Leukemia
      • Manhasset, New York
        Feinstein Institute for Medical research
      Jul 6, 2022

      Acute Lymphoblastic Leukemia Trial (chidamide, Venetoclax Oral Tablet, Inotuzumab Ozogamicin)

      Not yet recruiting
      • Acute Lymphoblastic Leukemia
      • (no location specified)
      Oct 19, 2023

      B-cell Acute Lymphoblastic Leukemia, Non-Hodgkin's Lymphoma, Relapsed, Non-Hodgkin's Lymphoma Refractory Trial in Taipei (RPM

      Terminated
      • B-cell Acute Lymphoblastic Leukemia
      • +7 more
      • RPM CD19-mbIL15-CAR-T cells
      • Taipei, Taiwan
        National Taiwan University Hospital
      May 11, 2022

      B Cell Repertoires in Chronic Lymphocytic Leukemia and Aging

      Active, not recruiting
      • Chronic Lymphocytic Leukemia
        • Manhasset, New York
          Feinstein Institute for Medical Research
        Jul 6, 2022

        Chronic Lymphocytic Leukemia Trial (Loncastuximab Tesirine)

        Not yet recruiting
        • Chronic Lymphocytic Leukemia
        • Loncastuximab Tesirine
        • (no location specified)
        Jul 24, 2023

        B-cell Lymphoma, Burkitt Lymphoma Trial in Milwaukee (Etoposide, Doxorubicin, Cyclophosphamide)

        Not yet recruiting
        • B-cell Lymphoma
        • Burkitt Lymphoma
        • Milwaukee, Wisconsin
          Froedtert Hospital & the Medical College of Wisconsin
        Jun 11, 2022

        Patients Who Received Inotuzumab Ozogamicin for B-cell ALL That

        Not yet recruiting
        • Adult Relapsed/Refractory B Cell Acute Lymphoblastic Leukemia
        • Inotuzumab Ozogamicin
        • (no location specified)
        Nov 3, 2022

        B-Cell Non Hodgkin Lymphoma, B-Cell Acute Lymphoblastic Leukemia Trial in Hanoi (anti-CD19 CAR T-cells)

        Recruiting
        • B-Cell Non Hodgkin Lymphoma
        • B-Cell Acute Lymphoblastic Leukemia
        • anti-CD19 CAR T-cells
        • Hanoi, Vietnam
          Vinmec Research Institute of Stem Cell and Gene Technology
        Sep 5, 2023

        Acute Lymphocytic Leukemia, Chronic Lymphocytic Leukemia, Non Hodgkin's Lymphoma Trial in Wuhan (Fludarabine + Cyclophosphamide

        Recruiting
        • Acute Lymphocytic Leukemia
        • +2 more
        • Fludarabine + Cyclophosphamide + CAR-NK-CD19 Cells
        • Wuhan, Hubei, China
          Union Hospital, Huazhong University of Science and Technology
        Apr 5, 2021

        Acute Lymphoid Leukemia, B-Cell Leukemia, Leukemia, Lymphocytic, B Cell Trial run by the National Cancer Institute (NCI)

        Not yet recruiting
        • Acute Lymphoid Leukemia
        • +4 more
        • Bethesda, Maryland
          National Institutes of Health Clinical Center
        Aug 17, 2022

        B-cell Acute Lymphoblastic Leukemia, B-Cell Lymphoma, Unspecified Trial in Guangzhou, Guanzhou (CD19 CAR T-Cell(CAT19T2))

        Not yet recruiting
        • B-cell Acute Lymphoblastic Leukemia
        • B-Cell Lymphoma, Unspecified
        • CD19 CAR T-Cell(CAT19T2)
        • Guangzhou, Guangdong, China
        • +1 more
        Nov 4, 2022